FIELD: medicine, pharmaceutics.
SUBSTANCE: application describes new pharmaceutical compositions of (2R,3R,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-4-fluor-2-isobutylryloxymethyl-4-methyl-tetrahydrofurane-3-yl ester of isooleic acid and hydroxypropyl cellulose. The composition contains 50 to 95 wt % of the above active agent, 1 to 4 wt % of hydroxypropyl cellulose and at least one excipient in the amount up to 49 wt %.
EFFECT: compositions according to the invention provide high bulk density, low granule size, more applicable for better compactibility, flowability and improved solubility profiles.
21 cl, 8 dwg, 11 tbl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
NEW COMPOSITION | 2006 |
|
RU2821230C2 |
ESCITALOPRAM AND HARD PHARMACETICAL COMPOSITION CONTAINING IT | 2007 |
|
RU2463039C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
PHARMACEUTICAL COMPOSITIONS, CONTAINING IMATINIB AND RELEASE MODERATOR | 2006 |
|
RU2404775C2 |
NOVEL COMPOSITION | 2006 |
|
RU2483716C2 |
FLUVASTATIN CONTAINING PHARMACEUTICAL COMPOSITIONS | 2001 |
|
RU2297223C2 |
GALENIC FORMULATIONS OF ALISKIREN | 2008 |
|
RU2483718C2 |
GALENA COMPOSITION OF ALISKIREN AND HYDROCHLOROTHIAZIDE | 2007 |
|
RU2491058C2 |
METHOD FOR MELT GRANULATION | 2009 |
|
RU2491918C2 |
PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING | 2004 |
|
RU2375048C2 |
Authors
Dates
2013-08-10—Published
2010-01-11—Filed